NEW YORK (GenomeWeb News) – Shares in Invitrogen were down approximately 9.8 percent, or $6.10, at $56.23 in mid-afternoon trading today after the company reported lower-than-expected revenues for the second quarter, and lowered its financial guidance.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.